Christopher J. Jemapete serves as Executive at Gene Biotherapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Christopher J. Jemapete has executed 2 insider transactions totaling $92.0K, demonstrating a bullish approach to their equity position. Their most recent transaction on Mar 17, 2021 involved purchasing 200,000 shares valued at $80.0K.
Christopher J. Jemapete currently holds 4,000,000 shares of Gene Biotherapeutics, Inc. (CRXM), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Christopher J. Jemapete has been a net buyer of CRXM stock. They have purchased $92.0K and sold $0 worth of shares.
Christopher J. Jemapete's most recent insider trade was on Mar 17, 2021, when they purchased 200,000 shares at $0.40 per share.
Get notified when new Form 4 filings are submitted
| $0.04 |
| Discretionary |